225 related articles for article (PubMed ID: 29564122)
1. Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.
Niiro E; Morioka S; Iwai K; Yamada Y; Ogawa K; Kawahara N; Kobayashi H
Biomed Rep; 2018 Mar; 8(3):215-223. PubMed ID: 29564122
[TBL] [Abstract][Full Text] [Related]
2. New steps in the Wnt/beta-catenin signal transduction pathway.
Sakanaka C; Sun TQ; Williams LT
Recent Prog Horm Res; 2000; 55():225-36. PubMed ID: 11036939
[TBL] [Abstract][Full Text] [Related]
3. Role of Wnt/β-catenin, Wnt/c-Jun N-terminal kinase and Wnt/Ca
Huang L; Jin Y; Feng S; Zou Y; Xu S; Qiu S; Li L; Zheng J
Exp Ther Med; 2016 Dec; 12(6):3851-3858. PubMed ID: 28101169
[TBL] [Abstract][Full Text] [Related]
4. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
5. MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway.
Gu ZW; He YF; Wang WJ; Tian Q; Di W
J Zhejiang Univ Sci B; 2019 Mar.; 20(3):219-237. PubMed ID: 30829010
[TBL] [Abstract][Full Text] [Related]
6. Cripto-1 contributes to stemness in hepatocellular carcinoma by stabilizing Dishevelled-3 and activating Wnt/β-catenin pathway.
Lo RC; Leung CO; Chan KK; Ho DW; Wong CM; Lee TK; Ng IO
Cell Death Differ; 2018 Aug; 25(8):1426-1441. PubMed ID: 29445127
[TBL] [Abstract][Full Text] [Related]
7. Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis.
Nguyen VHL; Hough R; Bernaudo S; Peng C
J Ovarian Res; 2019 Dec; 12(1):122. PubMed ID: 31829231
[TBL] [Abstract][Full Text] [Related]
8. Wnt3a ligand facilitates autophagy in hippocampal neurons by modulating a novel GSK-3β-AMPK axis.
Ríos JA; Godoy JA; Inestrosa NC
Cell Commun Signal; 2018 Apr; 16(1):15. PubMed ID: 29642895
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin and MAPK signaling: allies and enemies in different battlefields.
Guardavaccaro D; Clevers H
Sci Signal; 2012 Apr; 5(219):pe15. PubMed ID: 22494969
[TBL] [Abstract][Full Text] [Related]
10. Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.
Zhang C; Zhang Z; Zhang S; Wang W; Hu P
Med Sci Monit; 2017 Jan; 23():266-275. PubMed ID: 28090074
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
[TBL] [Abstract][Full Text] [Related]
12. Wnt/β-catenin signaling regulates follicular development by modulating the expression of Foxo3a signaling components.
Li L; Ji SY; Yang JL; Li XX; Zhang J; Zhang Y; Hu ZY; Liu YX
Mol Cell Endocrinol; 2014 Feb; 382(2):915-25. PubMed ID: 24246780
[TBL] [Abstract][Full Text] [Related]
13. Wnt antagonist as therapeutic targets in ovarian cancer.
Y KN; Perumalsamy NK; Warrier S; Perumalsamy LR; Dharmarajan A
Int J Biochem Cell Biol; 2022 Apr; 145():106191. PubMed ID: 35272015
[TBL] [Abstract][Full Text] [Related]
14. Trefoil factor 1 elevates the malignant phenotype of mucinous ovarian cancer cell through Wnt/β-catenin signaling.
Zhao S; Ma Y; Huang X
Int J Clin Exp Pathol; 2015; 8(9):10412-9. PubMed ID: 26617749
[TBL] [Abstract][Full Text] [Related]
15. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.
van de Schans VA; van den Borne SW; Strzelecka AE; Janssen BJ; van der Velden JL; Langen RC; Wynshaw-Boris A; Smits JF; Blankesteijn WM
Hypertension; 2007 Mar; 49(3):473-80. PubMed ID: 17210832
[TBL] [Abstract][Full Text] [Related]
16. The Wnt/β-catenin pathway in ovarian cancer: a review.
Arend RC; Londoño-Joshi AI; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2013 Dec; 131(3):772-9. PubMed ID: 24125749
[TBL] [Abstract][Full Text] [Related]
17. Gtpbp2 is a positive regulator of Wnt signaling and maintains low levels of the Wnt negative regulator Axin.
Gillis WQ; Kirmizitas A; Iwasaki Y; Ki DH; Wyrick JM; Thomsen GH
Cell Commun Signal; 2016 Aug; 14(1):15. PubMed ID: 27484226
[TBL] [Abstract][Full Text] [Related]
18. Cross-Talk between Wnt Signaling and Src Tyrosine Kinase.
Min JK; Park HS; Lee YB; Kim JG; Kim JI; Park JB
Biomedicines; 2022 May; 10(5):. PubMed ID: 35625853
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.
Arend RC; Londoño-Joshi AI; Samant RS; Li Y; Conner M; Hidalgo B; Alvarez RD; Landen CN; Straughn JM; Buchsbaum DJ
Gynecol Oncol; 2014 Jul; 134(1):112-20. PubMed ID: 24736023
[TBL] [Abstract][Full Text] [Related]
20. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: inhibitors of the Wnt/beta-catenin signaling pathway as novel anticancer drugs.
Takahashi-Yanaga F; Sasaguri T
J Pharmacol Sci; 2009 Feb; 109(2):179-83. PubMed ID: 19179804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
